Cite
HARVARD Citation
Mohlin, S. et al. (2020). Anti‐tumor effects of PIM/PI3K/mTOR triple kinase inhibitor IBL‐302 in neuroblastoma. EMBO molecular medicine. 12 (1), p. n/a. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Mohlin, S. et al. (2020). Anti‐tumor effects of PIM/PI3K/mTOR triple kinase inhibitor IBL‐302 in neuroblastoma. EMBO molecular medicine. 12 (1), p. n/a. [Online].